Daily News Podcast

Daily News Special: SABCS

Publish date: January 12, 2019

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Walking program eased chemo-related joint pain
MDedge Rheumatology
Exercise dampens aromatase inhibitor–related joint pain
MDedge Rheumatology
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge Rheumatology
VIDEO: Less frequent zoledronic acid is safe, retains efficacy
MDedge Rheumatology
Bisphosphonates don’t cut risk of breast cancer
MDedge Rheumatology
No rise in breast cancer recurrence found with TNF inhibitor use
MDedge Rheumatology
Apple’s ResearchKit
MDedge Rheumatology
Contamination prompts voluntary injectables recall
MDedge Rheumatology
Omega-3 fatty acids similar to placebo for aromatase inhibitor–induced musculoskeletal pain
MDedge Rheumatology
ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs
MDedge Rheumatology